Atlas Trials

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

Clinical trial NCT03418493 · COMPLETED

Trial details

NCT number
NCT03418493
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Psoriasis
Start date
2018-01-30
Primary completion
2018-12-24
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.